| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.78 | 0.005 | 0.78 | Aldehyde oxidase inhibitor | |||
| 0.738 | 0.005 | 0.738 | 5 Hydroxytryptamine release stimulant | 0.593 0.015 CID_154700010 | ||
| 0.749 | 0.018 | 0.749 | Caspase 9 stimulant | 0.723 0.021 CID_154700010 | ||
| 0.628 | 0.003 | 0.628 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.592 | 0.005 | 0.592 | Peroxidase inhibitor | |||
| 0.589 | 0.009 | 0.589 | GABA C receptor rho-3 antagonist | |||
| 0.584 | 0.013 | 0.652 | 5 Hydroxytryptamine release inhibitor | 0.652 0.006 CID_154700010 | CID_154700010 | |
| 0.588 | 0.02 | 0.756 | Cholesterol antagonist | 0.756 0.005 CID_154700010 | CID_154700010 | |
| 0.552 | 0.003 | 0.552 | Alcohol oxidase inhibitor | 0.061 0.035 CID_154700010 | ||
| 0.556 | 0.009 | 0.556 | Superoxide dismutase inhibitor | |||
| 0.537 | 0.016 | 0.537 | Calcium channel L-type activator | 0.262 0.193 CID_154700010 | ||
| 0.521 | 0.004 | 0.521 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.085 CID_154700010 | ||
| 0.535 | 0.019 | 0.661 | Histamine release inhibitor | 0.661 0.006 CID_154700010 | CID_154700010 | |
| 0.506 | 0.008 | 0.506 | Anesthetic general | 0.487 0.009 CID_154700010 | ||
| 0.498 | 0.004 | 0.51 | Neurotrophic factor enhancer | 0.51 0.004 CID_154700010 | CID_154700010 | |
| 0.455 | 0.007 | 0.686 | Alpha-N-acetylglucosaminidase inhibitor | 0.686 0.003 CID_154700010 | CID_154700010 | |
| 0.46 | 0.038 | 0.46 | Vasodilator, peripheral | 0.439 0.044 CID_154700010 | ||
| 0.423 | 0.004 | 0.423 | Estrogen receptor beta antagonist | |||
| 0.437 | 0.031 | 0.437 | 12-Lipoxygenase inhibitor | |||
| 0.408 | 0.004 | 0.408 | Estrogen antagonist | 0.11 0.074 CID_154700010 | ||
| 0.453 | 0.053 | 0.453 | 15-Lipoxygenase inhibitor | |||
| 0.407 | 0.011 | 0.594 | Melanin inhibitor | 0.594 0.004 CID_154700010 | CID_154700010 | |
| 0.404 | 0.01 | 0.404 | Phospholipase C inhibitor | 0.304 0.018 CID_154700010 | ||
| 0.445 | 0.054 | 0.742 | Transcription factor NF kappa B inhibitor | 0.742 0.017 CID_154700010 | CID_154700010 | |
| 0.416 | 0.026 | 0.627 | Free radical scavenger | 0.627 0.007 CID_154700010 | CID_154700010 | |
| 0.412 | 0.033 | 0.686 | Antioxidant | 0.686 0.006 CID_154700010 | CID_154700010 | |
| 0.396 | 0.019 | 0.396 | RNA-directed DNA polymerase inhibitor | 0.322 0.028 CID_154700010 | ||
| 0.392 | 0.019 | 0.392 | Sodium/bile acid cotransporter inhibitor | 0.309 0.071 CID_154700010 | ||
| 0.402 | 0.034 | 0.618 | Vasodilator, coronary | 0.618 0.007 CID_154700010 | CID_154700010 | |
| 0.392 | 0.028 | 0.392 | Calcium channel activator | |||
| 0.387 | 0.03 | 0.745 | Hypoglycemic | 0.745 0.004 CID_154700010 | CID_154700010 | |
| 0.359 | 0.004 | 0.359 | Porphobilinogen synthase inhibitor | |||
| 0.344 | 0.004 | 0.344 | GABA C receptor rho-2 antagonist | |||
| 0.346 | 0.007 | 0.346 | Cystathionine beta-synthase inhibitor | 0.293 0.01 CID_154700010 | ||
| 0.367 | 0.028 | 0.376 | Psychostimulant | 0.376 0.027 CID_154700010 | CID_154700010 | |
| 0.341 | 0.004 | 0.341 | Creatine kinase inhibitor | |||
| 0.339 | 0.005 | 0.339 | Nitric-oxide synthase stimulant | 0.337 0.005 CID_154700010 | ||
| 0.334 | 0.004 | 0.334 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.358 | 0.031 | 0.358 | Insulysin inhibitor | |||
| 0.332 | 0.008 | 0.332 | GABA C receptor agonist | |||
| 0.367 | 0.046 | 0.367 | Lipoxygenase inhibitor | |||
| 0.326 | 0.009 | 0.326 | Aldehyde dehydrogenase inhibitor | 0.281 0.014 CID_154700010 | ||
| 0.365 | 0.048 | 0.488 | Spasmolytic | 0.488 0.025 CID_154700010 | CID_154700010 | |
| 0.32 | 0.004 | 0.32 | GABA C receptor antagonist | |||
| 0.311 | 0.005 | 0.311 | Estrogen agonist | 0.094 0.019 CID_154700010 | ||
| 0.333 | 0.03 | 0.488 | Cyclic AMP phosphodiesterase inhibitor | 0.488 0.007 CID_154700010 | CID_154700010 | |
| 0.307 | 0.005 | 0.307 | Alcohol dehydrogenase inhibitor | 0.234 0.009 CID_154700010 | ||
| 0.4 | 0.101 | 0.4 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.314 | 0.016 | 0.64 | Amylase inhibitor | 0.64 0.004 CID_154700010 | CID_154700010 | |
| 0.304 | 0.006 | 0.304 | Histidine decarboxylase inhibitor | |||
| 0.372 | 0.075 | 0.561 | Immunosuppressant | 0.561 0.019 CID_154700010 | CID_154700010 | |
| 0.314 | 0.016 | 0.611 | Monophenol monooxygenase inhibitor | 0.611 0.005 CID_154700010 | CID_154700010 | |
| 0.344 | 0.048 | 0.486 | Interleukin 2 agonist | 0.486 0.01 CID_154700010 | CID_154700010 | |
| 0.305 | 0.01 | 0.467 | UDP-glucose 4-epimerase inhibitor | 0.467 0.003 CID_154700010 | CID_154700010 | |
| 0.325 | 0.037 | 0.481 | Interleukin agonist | 0.481 0.01 CID_154700010 | CID_154700010 | |
| 0.299 | 0.011 | 0.299 | Succinate dehydrogenase inhibitor | 0.167 0.084 CID_154700010 | ||
| 0.309 | 0.021 | 0.309 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.234 0.05 CID_154700010 | ||
| 0.323 | 0.037 | 0.484 | DNA synthesis inhibitor | 0.484 0.014 CID_154700010 | CID_154700010 | |
| 0.363 | 0.08 | 0.363 | Calpain 2 inhibitor | |||
| 0.291 | 0.008 | 0.291 | Ferrochelatase inhibitor | |||
| 0.347 | 0.066 | 0.762 | Antithrombotic | 0.762 0.005 CID_154700010 | CID_154700010 | |
| 0.318 | 0.043 | 0.318 | Pyruvate kinase inhibitor | |||
| 0.325 | 0.057 | 0.325 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.275 | 0.008 | 0.275 | Farnesoid X receptor antagonist | 0.118 0.109 CID_154700010 | ||
| 0.27 | 0.005 | 0.402 | Photosensitizer | 0.402 0.003 CID_154700010 | CID_154700010 | |
| 0.282 | 0.02 | 0.282 | Insulin sensitizer | 0.278 0.022 CID_154700010 | ||
| 0.264 | 0.003 | 0.264 | DOPA decarboxylase inhibitor | 0.103 0.07 CID_154700010 | ||
| 0.262 | 0.004 | 0.262 | GABA C receptor rho-1 antagonist | |||
| 0.279 | 0.022 | 0.378 | Lipid peroxidase inhibitor | 0.378 0.011 CID_154700010 | CID_154700010 | |
| 0.292 | 0.035 | 0.292 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.279 | 0.023 | 0.454 | Interferon gamma antagonist | 0.454 0.008 CID_154700010 | CID_154700010 | |
| 0.364 | 0.113 | 0.844 | Cyclophilin D inhibitor | 0.844 0.005 CID_154700010 | CID_154700010 | |
| 0.283 | 0.032 | 0.558 | Non-steroidal antiinflammatory agent | 0.558 0.005 CID_154700010 | CID_154700010 | |
| 0.254 | 0.004 | 0.254 | Estrogen receptor beta agonist | 0.061 0.017 CID_154700010 | ||
| 0.374 | 0.126 | 0.623 | Apoptosis agonist | 0.623 0.044 CID_154700010 | CID_154700010 | |
| 0.265 | 0.02 | 0.265 | Phospholipase A2 inhibitor | 0.234 0.028 CID_154700010 | ||
| 0.348 | 0.103 | 0.665 | Antibacterial | 0.665 0.012 CID_154700010 | CID_154700010 | |
| 0.256 | 0.011 | 0.256 | Carbonic anhydrase XV inhibitor | |||
| 0.306 | 0.063 | 0.341 | Hypoxia-inducible factor 1 alpha inhibitor | 0.341 0.048 CID_154700010 | CID_154700010 | |
| 0.3 | 0.056 | 0.3 | Transcription factor STAT inhibitor | |||
| 0.293 | 0.049 | 0.293 | Interleukin antagonist | |||
| 0.247 | 0.004 | 0.247 | GABA aminotransferase inhibitor | 0.203 0.004 CID_154700010 | ||
| 0.252 | 0.009 | 0.64 | Cyclooxygenase 3 inhibitor | 0.64 0.002 CID_154700010 | CID_154700010 | |
| 0.247 | 0.004 | 0.247 | Estrogen receptor alpha agonist | |||
| 0.26 | 0.019 | 0.26 | Neurotensin receptor agonist | |||
| 0.295 | 0.056 | 0.295 | Transcription factor STAT3 inhibitor | |||
| 0.256 | 0.017 | 0.256 | Cholesterol synthesis inhibitor | 0.183 0.031 CID_154700010 | ||
| 0.245 | 0.006 | 0.245 | Estrogen receptor alpha antagonist | |||
| 0.285 | 0.048 | 0.285 | Amyloid beta aggregation inhibitor | 0.152 0.106 CID_154700010 | ||
| 0.246 | 0.012 | 0.246 | Catenin beta inhibitor | |||
| 0.239 | 0.005 | 0.239 | Antineoplastic alkaloid | 0.088 0.056 CID_154700010 | ||
| 0.25 | 0.017 | 0.419 | Hexokinase inhibitor | 0.419 0.004 CID_154700010 | CID_154700010 | |
| 0.243 | 0.01 | 0.243 | Carbonic anhydrase III inhibitor | 0.131 0.037 CID_154700010 | ||
| 0.239 | 0.008 | 0.239 | CF transmembrane conductance regulator agonist | 0.179 0.037 CID_154700010 | ||
| 0.241 | 0.01 | 0.339 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.339 0.005 CID_154700010 | CID_154700010 | |
| 0.239 | 0.008 | 0.239 | Arachidonic acid antagonist | 0.196 0.037 CID_154700010 | ||
| 0.232 | 0.005 | 0.232 | Glutamate decarboxylase inhibitor | |||
| 0.233 | 0.007 | 0.233 | NMDA 2 receptor antagonist | |||
| 0.28 | 0.055 | 0.418 | Hypolipemic | 0.418 0.022 CID_154700010 | CID_154700010 | |
| 0.228 | 0.005 | 0.228 | Prolactin inhibitor | |||
| 0.245 | 0.022 | 0.245 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.229 | 0.007 | 0.229 | TRPA1 agonist | 0.15 0.031 CID_154700010 | ||
| 0.225 | 0.003 | 0.225 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.274 | 0.054 | 0.274 | Gastrin inhibitor | 0.238 0.094 CID_154700010 | ||
| 0.238 | 0.019 | 0.323 | Topoisomerase I inhibitor | 0.323 0.009 CID_154700010 | CID_154700010 | |
| 0.243 | 0.023 | 0.243 | Heat shock protein 90 antagonist | |||
| 0.246 | 0.027 | 0.424 | Protein kinase stimulant | 0.424 0.007 CID_154700010 | CID_154700010 | |
| 0.226 | 0.007 | 0.226 | Vanilloid 1 agonist | 0.204 0.011 CID_154700010 | ||
| 0.224 | 0.006 | 0.224 | Adenylate cyclase stimulant | 0.163 0.044 CID_154700010 | ||
| 0.259 | 0.043 | 0.348 | DNA methyltransferase I inhibitor | 0.348 0.014 CID_154700010 | CID_154700010 | |
| 0.24 | 0.023 | 0.24 | NADPH oxidase inhibitor | 0.167 0.045 CID_154700010 | ||
| 0.245 | 0.03 | 0.245 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.222 | 0.008 | 0.222 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.222 | 0.009 | 0.364 | Phosphofructokinase-1 inhibitor | 0.364 0.004 CID_154700010 | CID_154700010 | |
| 0.274 | 0.061 | 0.373 | Antiamyloidogenic | 0.373 0.034 CID_154700010 | CID_154700010 | |
| 0.222 | 0.011 | 0.222 | Carbonic anhydrase VI inhibitor | 0.093 0.044 CID_154700010 | ||
| 0.239 | 0.03 | 0.239 | Heat shock protein 90 alpha antagonist | |||
| 0.291 | 0.083 | 0.34 | Caspase 3 stimulant | 0.34 0.063 CID_154700010 | CID_154700010 | |
| 0.295 | 0.088 | 0.534 | Apoptosis antagonist | 0.534 0.016 CID_154700010 | CID_154700010 | |
| 0.221 | 0.015 | 0.221 | Toll-Like receptor 2 antagonist | |||
| 0.252 | 0.047 | 0.372 | DNA methylase inhibitor | 0.372 0.013 CID_154700010 | CID_154700010 | |
| 0.248 | 0.044 | 0.248 | Growth hormone agonist | |||
| 0.298 | 0.094 | 0.298 | Thyroid hormone antagonist | |||
| 0.233 | 0.03 | 0.376 | NOS3 expression enhancer | 0.376 0.009 CID_154700010 | CID_154700010 | |
| 0.252 | 0.05 | 0.436 | Peptidyltransferase inhibitor | 0.436 0.005 CID_154700010 | CID_154700010 | |
| 0.221 | 0.02 | 0.221 | 5-Lipoxygenase inhibitor | |||
| 0.257 | 0.058 | 0.257 | Calpain inhibitor | |||
| 0.212 | 0.013 | 0.212 | NMDA receptor antagonist | |||
| 0.206 | 0.008 | 0.206 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.219 | 0.022 | 0.23 | Mannose-6-phosphate isomerase inhibitor | 0.23 0.017 CID_154700010 | CID_154700010 | |
| 0.205 | 0.01 | 0.416 | Triose-phosphate isomerase inhibitor | 0.416 0.003 CID_154700010 | CID_154700010 | |
| 0.203 | 0.008 | 0.203 | Keratolytic | |||
| 0.223 | 0.03 | 0.308 | Interleukin 6 antagonist | 0.308 0.014 CID_154700010 | CID_154700010 | |
| 0.196 | 0.003 | 0.196 | Estrogen-related receptor beta agonist | |||
| 0.212 | 0.019 | 0.212 | Interleukin 4 antagonist | 0.169 0.036 CID_154700010 | ||
| 0.202 | 0.01 | 0.202 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.224 | 0.032 | 0.224 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.198 | 0.007 | 0.206 | Heat shock protein 70 antagonist | 0.206 0.005 CID_154700010 | CID_154700010 | |
| 0.198 | 0.008 | 0.198 | Macrophage migration inhibitory factor inhibitor | |||
| 0.213 | 0.024 | 0.213 | Adenylate cyclase inhibitor | 0.14 0.052 CID_154700010 | ||
| 0.207 | 0.02 | 0.207 | Aminopeptidase B inhibitor | |||
| 0.244 | 0.062 | 0.244 | Neuropeptide Y2 antagonist | |||
| 0.184 | 0.002 | 0.184 | Dopamine D5 agonist | |||
| 0.209 | 0.03 | 0.209 | Anesthetic local | |||
| 0.183 | 0.006 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 CID_154700010 | ||
| 0.267 | 0.09 | 0.545 | Immunostimulant | 0.545 0.023 CID_154700010 | CID_154700010 | |
| 0.323 | 0.149 | 0.581 | Alpha-glucosidase inhibitor | 0.581 0.058 CID_154700010 | CID_154700010 | |
| 0.245 | 0.072 | 0.411 | Vasodilator | 0.411 0.021 CID_154700010 | CID_154700010 | |
| 0.23 | 0.057 | 0.486 | Nitric oxide antagonist | 0.486 0.017 CID_154700010 | CID_154700010 | |
| 0.206 | 0.033 | 0.342 | ATPase inhibitor | 0.342 0.004 CID_154700010 | CID_154700010 | |
| 0.189 | 0.016 | 0.189 | Interleukin 8 antagonist | |||
| 0.178 | 0.005 | 0.178 | NMDA 2A receptor antagonist | |||
| 0.188 | 0.016 | 0.199 | Mucolytic | 0.199 0.014 CID_154700010 | CID_154700010 | |
| 0.273 | 0.103 | 0.273 | Thyroid hormone beta antagonist | |||
| 0.212 | 0.042 | 0.212 | Protein-tyrosine phosphatase inhibitor | 0.184 0.054 CID_154700010 | ||
| 0.215 | 0.048 | 0.215 | Lipocortins synthesis antagonist | 0.182 0.069 CID_154700010 | ||
| 0.175 | 0.01 | 0.175 | Adrenaline agonist | |||
| 0.2 | 0.036 | 0.405 | Insulin secretagoues | 0.405 0.006 CID_154700010 | CID_154700010 | |
| 0.179 | 0.015 | 0.179 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.176 | 0.013 | 0.176 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.26 | 0.097 | 0.26 | Streptokinase A inhibitor | |||
| 0.184 | 0.02 | 0.184 | 5 Hydroxytryptamine 3A agonist | |||
| 0.179 | 0.017 | 0.186 | Carbonic anhydrase XIII inhibitor | 0.186 0.016 CID_154700010 | CID_154700010 | |
| 0.175 | 0.013 | 0.354 | NADH dehydrogenase inhibitor | 0.354 0.005 CID_154700010 | CID_154700010 | |
| 0.171 | 0.009 | 0.171 | Anabolic | 0.115 0.044 CID_154700010 | ||
| 0.188 | 0.027 | 0.188 | Chelator | |||
| 0.166 | 0.005 | 0.166 | NMDA receptor subunit 3B antagonist | |||
| 0.165 | 0.005 | 0.165 | Bile acid receptor antagonist | 0.113 0.027 CID_154700010 | ||
| 0.177 | 0.019 | 0.177 | Adenylate kinase inhibitor | 0.143 0.029 CID_154700010 | ||
| 0.182 | 0.025 | 0.504 | Expectorant | 0.504 0.004 CID_154700010 | CID_154700010 | |
| 0.161 | 0.007 | 0.161 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.209 | 0.056 | 0.209 | Histone acetyltransferase inhibitor | |||
| 0.156 | 0.004 | 0.156 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.171 | 0.02 | 0.171 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.199 | 0.05 | 0.199 | Antipruritic | |||
| 0.162 | 0.013 | 0.162 | CYP2A6 inhibitor | |||
| 0.176 | 0.031 | 0.176 | Cathepsin H inhibitor | |||
| 0.156 | 0.011 | 0.156 | Aminopeptidase I inhibitor | |||
| 0.203 | 0.059 | 0.203 | Dual specificity phosphatase 3 inhibitor | |||
| 0.177 | 0.034 | 0.177 | MAO A inhibitor | |||
| 0.17 | 0.027 | 0.261 | Xanthine oxidase inhibitor | 0.261 0.011 CID_154700010 | CID_154700010 | |
| 0.178 | 0.036 | 0.188 | DNA polymerase I inhibitor | 0.188 0.032 CID_154700010 | CID_154700010 | |
| 0.182 | 0.041 | 0.182 | Bone formation stimulant | 0.136 0.071 CID_154700010 | ||
| 0.182 | 0.041 | 0.187 | Alkaline phosphatase inhibitor | 0.187 0.039 CID_154700010 | CID_154700010 | |
| 0.148 | 0.007 | 0.148 | Purinergic P2X1 antagonist | 0.08 0.025 CID_154700010 | ||
| 0.15 | 0.011 | 0.15 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.161 | 0.023 | 0.161 | Opioid antagonist | |||
| 0.143 | 0.004 | 0.143 | Nicotinic acid receptor agonist | |||
| 0.197 | 0.059 | 0.197 | Amyloid beta precursor protein antagonist | |||
| 0.299 | 0.162 | 0.299 | DNA directed DNA polymerase inhibitor | |||
| 0.141 | 0.005 | 0.141 | NMDA receptor subunit 3A antagonist | |||
| 0.172 | 0.037 | 0.181 | Protein-tyrosine phosphatase 1B inhibitor | 0.181 0.034 CID_154700010 | CID_154700010 | |
| 0.165 | 0.031 | 0.221 | Microtubule formation inhibitor | 0.221 0.015 CID_154700010 | CID_154700010 | |
| 0.162 | 0.028 | 0.162 | Bronchodilator | |||
| 0.228 | 0.094 | 0.255 | DNA damaging | 0.255 0.077 CID_154700010 | CID_154700010 | |
| 0.141 | 0.007 | 0.141 | Beta 3 adrenoreceptor antagonist | |||
| 0.155 | 0.021 | 0.155 | Androgen antagonist | |||
| 0.191 | 0.06 | 0.191 | Dual specificity phosphatase inhibitor | |||
| 0.216 | 0.087 | 0.802 | Angiogenesis stimulant | 0.802 0.004 CID_154700010 | CID_154700010 | |
| 0.151 | 0.023 | 0.151 | Transcription factor STAT6 inhibitor | |||
| 0.136 | 0.008 | 0.136 | NMDA 2C receptor antagonist | |||
| 0.16 | 0.032 | 0.16 | Falcipain 3 inhibitor | |||
| 0.136 | 0.009 | 0.136 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.18 | 0.054 | 0.389 | Diuretic | 0.389 0.014 CID_154700010 | CID_154700010 | |
| 0.147 | 0.021 | 0.147 | Electrolyte absorption antagonist | |||
| 0.15 | 0.024 | 0.15 | Sphingomyelinase inhibitor | 0.138 0.03 CID_154700010 | ||
| 0.148 | 0.024 | 0.148 | Urease inhibitor | |||
| 0.171 | 0.047 | 0.171 | Cyclooxygenase 1 inhibitor | 0.103 0.097 CID_154700010 | ||
| 0.142 | 0.018 | 0.142 | Opioid kappa receptor antagonist | |||
| 0.193 | 0.069 | 0.533 | Hepatoprotectant | 0.533 0.006 CID_154700010 | CID_154700010 | |
| 0.166 | 0.043 | 0.166 | Neuropeptide Y1 antagonist | |||
| 0.136 | 0.013 | 0.136 | Vanilloid agonist | 0.081 0.068 CID_154700010 | ||
| 0.128 | 0.006 | 0.128 | CC chemokine 5 receptor agonist | |||
| 0.131 | 0.009 | 0.131 | D-Ala-D-Ala ligase inhibitor | |||
| 0.195 | 0.074 | 0.476 | Platelet adhesion inhibitor | 0.476 0.006 CID_154700010 | CID_154700010 | |
| 0.248 | 0.127 | 0.248 | Prostaglandin dehydrogenase inhibitor | |||
| 0.139 | 0.018 | 0.139 | Histamine N-methyltransferase inhibitor | |||
| 0.132 | 0.012 | 0.132 | Biliverdin reductase inhibitor | 0.091 0.021 CID_154700010 | ||
| 0.147 | 0.027 | 0.147 | Catalase inhibitor | |||
| 0.186 | 0.067 | 0.186 | Sigma receptor agonist | |||
| 0.171 | 0.051 | 0.171 | MAO inhibitor | |||
| 0.125 | 0.006 | 0.125 | GABA B receptor agonist | |||
| 0.136 | 0.018 | 0.136 | Glutamate dehydrogenase inhibitor | 0.096 0.033 CID_154700010 | ||
| 0.166 | 0.049 | 0.166 | Nav1.2 sodium channel blocker | |||
| 0.134 | 0.017 | 0.134 | Ornithine decarboxylase inhibitor | 0.113 0.032 CID_154700010 | ||
| 0.157 | 0.041 | 0.157 | Pregnane X receptor agonist | |||
| 0.154 | 0.038 | 0.178 | Beta amyloid protein antagonist | 0.178 0.025 CID_154700010 | CID_154700010 | |
| 0.164 | 0.048 | 0.164 | M17 leucyl aminopeptidase inhibitor | |||
| 0.126 | 0.011 | 0.126 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.124 0.011 CID_154700010 | ||
| 0.172 | 0.057 | 0.172 | Acetylcholine M1 receptor antagonist | |||
| 0.137 | 0.022 | 0.137 | Opioid delta receptor antagonist | |||
| 0.127 | 0.011 | 0.127 | Carbonic anhydrase VB inhibitor | |||
| 0.166 | 0.051 | 0.344 | Cell wall synthesis inhibitor | 0.344 0.008 CID_154700010 | CID_154700010 | |
| 0.144 | 0.03 | 0.144 | Potassium channel (Ca-activated) activator | |||
| 0.119 | 0.005 | 0.119 | Sphingosine kinase 2 inhibitor | |||
| 0.127 | 0.014 | 0.18 | Glycine receptor antagonist | 0.18 0.004 CID_154700010 | CID_154700010 | |
| 0.134 | 0.021 | 0.134 | Opioid mu receptor antagonist | |||
| 0.12 | 0.008 | 0.12 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.122 | 0.01 | 0.122 | Beta adrenoreceptor antagonist | |||
| 0.157 | 0.046 | 0.157 | Nav1.6 sodium channel blocker | |||
| 0.135 | 0.024 | 0.135 | Cathepsin G inhibitor | |||
| 0.116 | 0.005 | 0.116 | MAP kinase kinase 7 inhibitor | |||
| 0.143 | 0.033 | 0.425 | AMP-activated protein kinase stimulant | 0.425 0.004 CID_154700010 | CID_154700010 | |
| 0.13 | 0.019 | 0.13 | Carbonic anhydrase V inhibitor | |||
| 0.137 | 0.027 | 0.146 | Acetylcholine release stimulant | 0.146 0.019 CID_154700010 | CID_154700010 | |
| 0.113 | 0.004 | 0.113 | Adenylate cyclase 1 inhibitor | |||
| 0.137 | 0.028 | 0.185 | Uric acid excretion stimulant | 0.185 0.015 CID_154700010 | CID_154700010 | |
| 0.118 | 0.01 | 0.118 | Androgen agonist | |||
| 0.114 | 0.006 | 0.114 | Potassium channel Kv1.3 blocker | |||
| 0.127 | 0.019 | 0.127 | HIV-1 reverse transcriptase inhibitor | |||
| 0.152 | 0.045 | 0.152 | Proteasome inhibitor | |||
| 0.142 | 0.035 | 0.165 | CC chemokine 6 receptor antagonist | 0.165 0.01 CID_154700010 | CID_154700010 | |
| 0.113 | 0.008 | 0.113 | Heat shock protein 90 beta antagonist | |||
| 0.12 | 0.015 | 0.12 | Argininosuccinate synthase inhibitor | 0.082 0.024 CID_154700010 | ||
| 0.141 | 0.037 | 0.141 | Nav1.1 sodium channel blocker | |||
| 0.11 | 0.006 | 0.11 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.117 | 0.014 | 0.117 | Glycine receptor agonist | 0.102 0.019 CID_154700010 | ||
| 0.118 | 0.016 | 0.118 | Leukotriene antagonist | 0.11 0.018 CID_154700010 | ||
| 0.124 | 0.023 | 0.124 | Inducible nitric-oxide synthase inhibitor | |||
| 0.165 | 0.065 | 0.165 | Cytidine deaminase inhibitor | |||
| 0.119 | 0.018 | 0.119 | Carbonic anhydrase VA inhibitor | |||
| 0.104 | 0.005 | 0.104 | Dihydroorotate oxidase inhibitor | |||
| 0.149 | 0.05 | 0.295 | Topoisomerase II inhibitor | 0.295 0.018 CID_154700010 | CID_154700010 | |
| 0.107 | 0.009 | 0.107 | Beta 1 adrenoreceptor antagonist | |||
| 0.114 | 0.015 | 0.114 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.107 | 0.009 | 0.175 | Leukotriene B4 antagonist | 0.175 0.004 CID_154700010 | CID_154700010 | |
| 0.133 | 0.035 | 0.35 | Beta glucuronidase inhibitor | 0.35 0.005 CID_154700010 | CID_154700010 | |
| 0.103 | 0.008 | 0.103 | Beta 2 adrenoreceptor antagonist | |||
| 0.104 | 0.009 | 0.104 | Glutamate (mGluR7) antagonist | |||
| 0.108 | 0.012 | 0.108 | 5 Hydroxytryptamine 2A agonist | |||
| 0.102 | 0.007 | 0.102 | Sphingosine kinase inhibitor | |||
| 0.116 | 0.024 | 0.126 | Glutamate release inhibitor | 0.126 0.019 CID_154700010 | CID_154700010 | |
| 0.097 | 0.006 | 0.097 | Calcium channel P-type blocker | |||
| 0.126 | 0.035 | 0.126 | Nitric-oxide synthase inhibitor | |||
| 0.105 | 0.015 | 0.105 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 CID_154700010 | ||
| 0.128 | 0.038 | 0.128 | Gastric antisecretory | |||
| 0.107 | 0.018 | 0.107 | Carbamoyl phosphate synthetase inhibitor | 0.061 0.042 CID_154700010 | ||
| 0.114 | 0.025 | 0.114 | Analgesic, opioid | |||
| 0.113 | 0.024 | 0.113 | Myeloperoxidase inhibitor | |||
| 0.091 | 0.004 | 0.091 | Pregnane X receptor antagonist | |||
| 0.114 | 0.029 | 0.114 | Alpha 2d adrenoreceptor antagonist | |||
| 0.089 | 0.003 | 0.089 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.301 | 0.215 | 0.8 | Antiinflammatory | 0.8 0.015 CID_154700010 | CID_154700010 | |
| 0.166 | 0.081 | 0.166 | Tumour necrosis factor antagonist | |||
| 0.103 | 0.018 | 0.103 | Potassium channel Kv1.5 blocker | |||
| 0.14 | 0.056 | 0.14 | Antibacterial (Helicobacter pylori) | |||
| 0.089 | 0.005 | 0.089 | Beta 2 adrenoreceptor agonist | |||
| 0.098 | 0.015 | 0.098 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.133 | 0.05 | 0.249 | DNA repair enzyme inhibitor | 0.249 0.005 CID_154700010 | CID_154700010 | |
| 0.087 | 0.004 | 0.087 | Dopamine beta hydroxylase inhibitor | |||
| 0.089 | 0.007 | 0.089 | Squalene epoxidase inhibitor | 0.046 0.042 CID_154700010 | ||
| 0.089 | 0.007 | 0.089 | Nicotinic acid receptor 2 agonist | |||
| 0.113 | 0.032 | 0.164 | Phosphodiesterase 6D inhibitor | 0.164 0.007 CID_154700010 | CID_154700010 | |
| 0.115 | 0.034 | 0.151 | Thioredoxin inhibitor | 0.151 0.016 CID_154700010 | CID_154700010 | |
| 0.095 | 0.014 | 0.095 | Glycine transporter 2 inhibitor | |||
| 0.091 | 0.01 | 0.091 | Aconitate hydratase inhibitor | |||
| 0.091 | 0.011 | 0.091 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.106 | 0.027 | 0.106 | Purinergic P2X2 antagonist | |||
| 0.082 | 0.003 | 0.082 | Estrogen-related receptor beta antagonist | |||
| 0.148 | 0.07 | 0.148 | Thiol protease inhibitor | |||
| 0.148 | 0.07 | 0.464 | Hemostatic | 0.464 0.005 CID_154700010 | CID_154700010 | |
| 0.104 | 0.026 | 0.104 | Peroxisome proliferator-activated receptor gamma agonist | 0.075 0.044 CID_154700010 | ||
| 0.081 | 0.004 | 0.174 | Sodium/glucose cotransporter 2 inhibitor | 0.174 0.001 CID_154700010 | CID_154700010 | |
| 0.094 | 0.017 | 0.094 | Alpha 2 adrenoreceptor agonist | |||
| 0.168 | 0.091 | 0.182 | P-glycoprotein inhibitor | 0.182 0.078 CID_154700010 | CID_154700010 | |
| 0.133 | 0.057 | 0.261 | Alkylator | 0.261 0.015 CID_154700010 | CID_154700010 | |
| 0.081 | 0.005 | 0.081 | GABA uptake inhibitor | |||
| 0.091 | 0.015 | 0.091 | Glutamate (mGluR6) antagonist | 0.063 0.056 CID_154700010 | ||
| 0.261 | 0.186 | 0.261 | DNA polymerase beta inhibitor | |||
| 0.103 | 0.029 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_154700010 | CID_154700010 | |
| 0.097 | 0.022 | 0.097 | Aromatase inhibitor | |||
| 0.081 | 0.007 | 0.081 | Retinoid X alpha receptor agonist | |||
| 0.079 | 0.006 | 0.079 | Immunoglobulin Fc receptor antagonist | |||
| 0.111 | 0.039 | 0.133 | Interleukin 12 antagonist | 0.133 0.02 CID_154700010 | CID_154700010 | |
| 0.118 | 0.046 | 0.184 | Toll-Like receptor 4 antagonist | 0.184 0.009 CID_154700010 | CID_154700010 | |
| 0.124 | 0.054 | 0.124 | Caspase 3 inhibitor | |||
| 0.091 | 0.021 | 0.091 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.078 | 0.009 | 0.078 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.074 | 0.005 | 0.074 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.087 | 0.019 | 0.087 | NMDA 2B receptor antagonist | |||
| 0.077 | 0.008 | 0.077 | Retinoid X receptor agonist | |||
| 0.073 | 0.005 | 0.073 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.073 | 0.006 | 0.073 | Geranyltranstransferase inhibitor | |||
| 0.076 | 0.009 | 0.076 | Leukotriene C antagonist | |||
| 0.074 | 0.007 | 0.074 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.088 | 0.022 | 0.088 | Potassium channel (ATP-sensitive) blocker | |||
| 0.084 | 0.017 | 0.084 | Phosphodiesterase 1C inhibitor | |||
| 0.153 | 0.087 | 0.153 | Mcl-1 antagonist | |||
| 0.097 | 0.031 | 0.13 | Interferon agonist | 0.13 0.014 CID_154700010 | CID_154700010 | |
| 0.1 | 0.034 | 0.1 | Somatostatin 1 agonist | |||
| 0.107 | 0.042 | 0.107 | ABCA1 expression enhancer | |||
| 0.077 | 0.012 | 0.228 | Alpha-mannosidase inhibitor | 0.228 0.003 CID_154700010 | CID_154700010 | |
| 0.157 | 0.092 | 0.157 | Death-associated protein kinase 2 inhibitor | |||
| 0.089 | 0.024 | 0.089 | NMDA receptor agonist | |||
| 0.075 | 0.011 | 0.075 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.076 | 0.012 | 0.076 | Ryanodine receptor antagonist | |||
| 0.068 | 0.004 | 0.231 | Sodium/glucose cotransporter inhibitor | 0.231 0.001 CID_154700010 | CID_154700010 | |
| 0.074 | 0.011 | 0.112 | Glucose-6-phosphate isomerase inhibitor | 0.112 0.004 CID_154700010 | CID_154700010 | |
| 0.073 | 0.01 | 0.073 | Urate transporter 1 inhibitor | |||
| 0.082 | 0.019 | 0.097 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.097 0.015 CID_154700010 | CID_154700010 | |
| 0.109 | 0.046 | 0.109 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.136 | 0.073 | 0.136 | Neurotrophic factor | 0.121 0.093 CID_154700010 | ||
| 0.066 | 0.004 | 0.066 | Thyroid hormone agonist | |||
| 0.085 | 0.023 | 0.085 | TRPA1 antagonist | |||
| 0.096 | 0.034 | 0.096 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.085 | 0.023 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.065 | 0.005 | 0.08 | Uridine phosphorylase inhibitor | 0.08 0.003 CID_154700010 | CID_154700010 | |
| 0.079 | 0.018 | 0.079 | Opioid mu receptor agonist | |||
| 0.088 | 0.029 | 0.088 | Dopamine D1 antagonist | |||
| 0.084 | 0.026 | 0.084 | NMDA receptor glycine site agonist | |||
| 0.098 | 0.039 | 0.098 | Glutathione S-transferase inhibitor | |||
| 0.087 | 0.029 | 0.087 | Secretase beta inhibitor | |||
| 0.076 | 0.018 | 0.076 | Glucosylceramidase inhibitor | 0.051 0.045 CID_154700010 | ||
| 0.067 | 0.01 | 0.067 | Liver X receptor alpha agonist | |||
| 0.081 | 0.023 | 0.105 | Interferon inducer | 0.105 0.011 CID_154700010 | CID_154700010 | |
| 0.09 | 0.033 | 0.09 | Lipase inhibitor | |||
| 0.182 | 0.125 | 0.487 | Tumour necrosis factor alpha release inhibitor | 0.487 0.015 CID_154700010 | CID_154700010 | |
| 0.07 | 0.013 | 0.07 | Adenosine deaminase inhibitor | 0.067 0.015 CID_154700010 | ||
| 0.188 | 0.131 | 0.188 | Cardiotonic | |||
| 0.068 | 0.011 | 0.068 | Oxytocin agonist | |||
| 0.1 | 0.044 | 0.1 | Phosphodiesterase I inhibitor | |||
| 0.113 | 0.057 | 0.113 | Electron transport complex I inhibitor | |||
| 0.075 | 0.02 | 0.075 | Peroxisome proliferator-activated receptor alpha agonist | 0.044 0.037 CID_154700010 | ||
| 0.064 | 0.009 | 0.07 | Guanylate cyclase inhibitor | 0.07 0.005 CID_154700010 | CID_154700010 | |
| 0.076 | 0.021 | 0.076 | Fatty acid synthase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.08 | 0.025 | 0.08 | Exportin-1 inhibitor | |||
| 0.062 | 0.007 | 0.062 | Beta adrenoreceptor agonist | |||
| 0.067 | 0.013 | 0.233 | Mannosidase inhibitor | 0.233 0.003 CID_154700010 | CID_154700010 | |
| 0.058 | 0.003 | 0.058 | Nicotinic acid receptor 2 antagonist | |||
| 0.064 | 0.01 | 0.064 | Dihydropteroate synthase inhibitor | |||
| 0.06 | 0.006 | 0.06 | Heme oxygenase inhibitor | |||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | |||
| 0.063 | 0.01 | 0.063 | Fumarate hydratase inhibitor | 0.047 0.015 CID_154700010 | ||
| 0.066 | 0.013 | 0.066 | Sphingosine 1-phosphate receptor agonist | |||
| 0.244 | 0.191 | 0.244 | Transcription factor inhibitor | |||
| 0.088 | 0.034 | 0.088 | Adenosine A3 receptor antagonist | |||
| 0.07 | 0.017 | 0.07 | Topoisomerase II beta inhibitor | 0.051 0.031 CID_154700010 | ||
| 0.067 | 0.014 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.084 | 0.032 | 0.084 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.086 | 0.034 | 0.086 | HIV-1 integrase inhibitor | |||
| 0.119 | 0.067 | 0.119 | Acetylcholine muscarinic antagonist | |||
| 0.094 | 0.041 | 0.094 | mTOR complex 2 inhibitor | |||
| 0.067 | 0.015 | 0.067 | CXC chemokine 1 receptor antagonist | |||
| 0.108 | 0.056 | 0.108 | MAO B inhibitor | |||
| 0.106 | 0.054 | 0.108 | Folate antagonist | 0.108 0.051 CID_154700010 | CID_154700010 | |
| 0.057 | 0.005 | 0.057 | Leukotriene B4 receptor 1 antagonist | 0.041 0.011 CID_154700010 | ||
| 0.065 | 0.013 | 0.065 | Cholesterol esterase inhibitor | |||
| 0.103 | 0.052 | 0.103 | Breast cancer-resistant protein inhibitor | |||
| 0.139 | 0.088 | 0.139 | MAP kinase kinase 4 inhibitor | |||
| 0.07 | 0.02 | 0.108 | Carbonic anhydrase XIV inhibitor | 0.108 0.009 CID_154700010 | CID_154700010 | |
| 0.085 | 0.035 | 0.085 | Alpha adrenoreceptor agonist | |||
| 0.056 | 0.006 | 0.056 | Liver X receptor beta antagonist | |||
| 0.058 | 0.009 | 0.058 | Glutamate (mGluR3) antagonist | |||
| 0.072 | 0.023 | 0.072 | Alpha tubulin antagonist | |||
| 0.076 | 0.026 | 0.076 | MDM2 inhibitor | |||
| 0.066 | 0.017 | 0.066 | Vanilloid 2 antagonist | |||
| 0.057 | 0.008 | 0.057 | Glutamate (mGluR8) agonist | |||
| 0.068 | 0.019 | 0.068 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.073 | 0.025 | 0.073 | Cyclin D1 inhibitor | |||
| 0.121 | 0.073 | 0.121 | Glutamate receptor antagonist | |||
| 0.054 | 0.007 | 0.054 | ATP citrate lysase inhibitor | |||
| 0.066 | 0.019 | 0.066 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.108 | 0.061 | 0.25 | Mediator release inhibitor | 0.25 0.01 CID_154700010 | CID_154700010 | |
| 0.05 | 0.003 | 0.05 | Estrogen-related receptor gamma antagonist | |||
| 0.054 | 0.007 | 0.054 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.083 | 0.036 | 0.083 | Vanilloid 4 agonist | |||
| 0.057 | 0.011 | 0.057 | Sphingosine kinase 1 inhibitor | |||
| 0.067 | 0.021 | 0.067 | Epithelial sodium channel blocker | |||
| 0.054 | 0.009 | 0.054 | Retinoid X receptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Leukotriene B4 receptor 2 antagonist | 0.038 0.005 CID_154700010 | ||
| 0.072 | 0.028 | 0.072 | Maillard reaction inhibitor | |||
| 0.071 | 0.028 | 0.071 | Transcription factor RelA inhibitor | |||
| 0.046 | 0.003 | 0.075 | Vanilloid 2 agonist | 0.075 0.002 CID_154700010 | CID_154700010 | |
| 0.052 | 0.009 | 0.052 | Leukotriene C4 antagonist | |||
| 0.057 | 0.015 | 0.057 | Thymidine kinase inhibitor | |||
| 0.044 | 0.003 | 0.044 | Nicotinic acid receptor 1 antagonist | |||
| 0.052 | 0.012 | 0.052 | Potassium channel Kv1.1 blocker | |||
| 0.071 | 0.031 | 0.071 | Carbonic anhydrase stimulant | |||
| 0.046 | 0.006 | 0.046 | Glutamate (mGluR3) agonist | |||
| 0.043 | 0.003 | 0.043 | Estrogen-related receptor gamma agonist | |||
| 0.103 | 0.063 | 0.103 | Alpha 2c adrenoreceptor antagonist | |||
| 0.078 | 0.038 | 0.078 | Phospholipase D inhibitor | |||
| 0.061 | 0.021 | 0.25 | Heparanase inhibitor | 0.25 0.002 CID_154700010 | CID_154700010 | |
| 0.1 | 0.06 | 0.1 | Glutamate (mGluR7) agonist | |||
| 0.07 | 0.031 | 0.07 | Xanthine dehydrogenase inhibitor | |||
| 0.155 | 0.116 | 0.155 | MAP kinase kinase 2 inhibitor | |||
| 0.056 | 0.017 | 0.056 | AICAR transformylase inhibitor | |||
| 0.056 | 0.018 | 0.056 | Purinergic P2X4 antagonist | |||
| 0.064 | 0.026 | 0.064 | Sigma receptor antagonist | |||
| 0.056 | 0.018 | 0.075 | Cytokine production stimulant | 0.075 0.006 CID_154700010 | CID_154700010 | |
| 0.052 | 0.015 | 0.052 | Alpha 1d adrenoreceptor agonist | |||
| 0.058 | 0.021 | 0.058 | Aldosterone antagonist | |||
| 0.046 | 0.009 | 0.046 | Cholesterol ester transfer protein antagonist | |||
| 0.069 | 0.032 | 0.069 | Phosphodiesterase 1B inhibitor | |||
| 0.052 | 0.015 | 0.052 | Angiotensin AT1 receptor antagonist | |||
| 0.067 | 0.03 | 0.067 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.068 | 0.032 | 0.068 | Ribonucleotide reductase inhibitor | |||
| 0.063 | 0.027 | 0.063 | Opioid agonist | |||
| 0.047 | 0.011 | 0.047 | CF transmembrane conductance regulator antagonist | |||
| 0.057 | 0.021 | 0.057 | Carbonic anhydrase VII inhibitor | |||
| 0.063 | 0.027 | 0.063 | Cannabinoid CB2 receptor antagonist | |||
| 0.069 | 0.033 | 0.069 | Acetylcholine M3 receptor antagonist | |||
| 0.093 | 0.057 | 0.093 | Potassium channel activator | |||
| 0.127 | 0.091 | 0.127 | Cyclooxygenase inhibitor | |||
| 0.057 | 0.021 | 0.064 | Factor III inhibitor | 0.064 0.014 CID_154700010 | CID_154700010 | |
| 0.058 | 0.023 | 0.058 | Potassium channel (Inward rectifier) activator | |||
| 0.045 | 0.01 | 0.045 | Retinoid X alpha receptor antagonist | |||
| 0.067 | 0.032 | 0.067 | Histone deacetylase SIRT3 inhibitor | |||
| 0.069 | 0.035 | 0.069 | Beta tubulin antagonist | |||
| 0.051 | 0.017 | 0.051 | Dihydrofolate reductase inhibitor | |||
| 0.05 | 0.015 | 0.05 | AMPA 4 receptor antagonist | |||
| 0.043 | 0.009 | 0.043 | Purinergic P2Y14 antagonist | |||
| 0.104 | 0.07 | 0.104 | Nav1.4 sodium channel blocker | |||
| 0.045 | 0.012 | 0.045 | Free fatty acid receptor 1 antagonist | |||
| 0.055 | 0.022 | 0.055 | Potassium channel (ATP-sensitive) activator | |||
| 0.116 | 0.084 | 0.116 | Tubulin antagonist | |||
| 0.093 | 0.06 | 0.093 | Protein kinase C zeta inhibitor | |||
| 0.047 | 0.015 | 0.047 | Phosphoglycerate kinase inhibitor | |||
| 0.047 | 0.015 | 0.047 | 5 Hydroxytryptamine 2B agonist | |||
| 0.066 | 0.034 | 0.066 | Glutamate (mGluR1) antagonist | |||
| 0.073 | 0.041 | 0.073 | Protein kinase C beta inhibitor | |||
| 0.046 | 0.015 | 0.046 | Estrogen-related receptor alpha antagonist | |||
| 0.103 | 0.072 | 0.103 | Protein kinase C gamma inhibitor | |||
| 0.069 | 0.039 | 0.069 | Aryl hydrocarbon receptor antagonist | |||
| 0.044 | 0.013 | 0.044 | Liver X receptor beta agonist | |||
| 0.052 | 0.022 | 0.052 | Leukocyte elastase inhibitor | |||
| 0.088 | 0.058 | 0.09 | Interleukin 5 antagonist | 0.09 0.055 CID_154700010 | CID_154700010 | |
| 0.044 | 0.014 | 0.044 | Vanilloid 3 antagonist | |||
| 0.067 | 0.037 | 0.067 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.077 | 0.047 | 0.085 | Phosphodiesterase VI inhibitor | 0.085 0.034 CID_154700010 | CID_154700010 | |
| 0.046 | 0.017 | 0.046 | Diamine oxidase inhibitor | |||
| 0.059 | 0.03 | 0.059 | Thromboxane synthase inhibitor | |||
| 0.071 | 0.043 | 0.071 | Potassium channel large-conductance Ca-activated activator | |||
| 0.041 | 0.013 | 0.041 | Prostaglandin agonist | |||
| 0.06 | 0.032 | 0.06 | Ornithine carbamoyltransferase inhibitor | |||
| 0.035 | 0.007 | 0.035 | Prostaglandin F2 alpha agonist | |||
| 0.035 | 0.008 | 0.035 | DNA polymerase III inhibitor | |||
| 0.041 | 0.014 | 0.041 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.059 | 0.031 | 0.077 | Adenine nucleotide translocase inhibitor | 0.077 0.01 CID_154700010 | CID_154700010 | |
| 0.041 | 0.014 | 0.041 | Angiotensin II receptor antagonist | |||
| 0.067 | 0.041 | 0.067 | CDC25B inhibitor | |||
| 0.082 | 0.055 | 0.082 | Ca(v)3.1 blocker | |||
| 0.03 | 0.004 | 0.048 | Antibiotic Anthracycline-like | 0.048 0.002 CID_154700010 | CID_154700010 | |
| 0.046 | 0.02 | 0.046 | 5-Alpha-reductase inhibitor | |||
| 0.054 | 0.028 | 0.054 | CD45 antagonist | |||
| 0.039 | 0.013 | 0.039 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.04 | 0.014 | 0.04 | Catechol O-methyltransferase inhibitor | |||
| 0.051 | 0.025 | 0.051 | Purinergic P2Y antagonist | |||
| 0.063 | 0.038 | 0.063 | Heme oxygenase stimulant | |||
| 0.04 | 0.015 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.03 | 0.004 | 0.03 | Alpha 2b adrenoreceptor agonist | |||
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.048 | 0.022 | 0.048 | GABA B receptor antagonist | |||
| 0.1 | 0.075 | 0.1 | Alpha 2b adrenoreceptor antagonist | |||
| 0.061 | 0.036 | 0.061 | Botulinum neurotoxin type A inhibitor | |||
| 0.033 | 0.008 | 0.033 | Hedgehog signaling activator | |||
| 0.063 | 0.038 | 0.08 | Prostaglandin EP2 antagonist | 0.08 0.027 CID_154700010 | CID_154700010 | |
| 0.069 | 0.045 | 0.069 | Leukotriene synthesis inhibitor | |||
| 0.029 | 0.005 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 CID_154700010 | ||
| 0.035 | 0.01 | 0.035 | Prostaglandin EP2 agonist | |||
| 0.063 | 0.038 | 0.063 | Acetylcholine M5 receptor antagonist | |||
| 0.055 | 0.03 | 0.114 | Glucose-6-phosphate translocase inhibitor | 0.114 0.005 CID_154700010 | CID_154700010 | |
| 0.056 | 0.032 | 0.056 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.034 | 0.01 | 0.034 | CXC chemokine 2 receptor antagonist | |||
| 0.028 | 0.005 | 0.028 | NMDA receptor phencyclidine site antagonist | |||
| 0.109 | 0.085 | 0.109 | Cholinergic antagonist | |||
| 0.078 | 0.054 | 0.078 | Metalloproteinase-2 inhibitor | |||
| 0.073 | 0.05 | 0.073 | Metalloproteinase-9 inhibitor | |||
| 0.028 | 0.005 | 0.028 | Retinoid X beta receptor antagonist | |||
| 0.04 | 0.017 | 0.04 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.05 | 0.027 | 0.05 | Thymidylate synthase inhibitor | |||
| 0.035 | 0.012 | 0.035 | Liver X receptor alpha antagonist | |||
| 0.028 | 0.005 | 0.069 | Ileal bile acid transport inhibitor | 0.069 0.003 CID_154700010 | CID_154700010 | |
| 0.03 | 0.008 | 0.03 | Beta 1 adrenoreceptor agonist | |||
| 0.042 | 0.02 | 0.076 | Arginase inhibitor | 0.076 0.006 CID_154700010 | CID_154700010 | |
| 0.031 | 0.009 | 0.031 | Acid ceramidase inhibitor | |||
| 0.036 | 0.014 | 0.036 | Sigma 1 receptor antagonist | |||
| 0.066 | 0.044 | 0.066 | Glucagon-like peptide 1 agonist | |||
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | |||
| 0.052 | 0.031 | 0.052 | Bombesin 2 receptor antagonist | |||
| 0.04 | 0.019 | 0.04 | Opioid delta receptor agonist | |||
| 0.105 | 0.085 | 0.105 | Acetylcholine antagonist | |||
| 0.078 | 0.057 | 0.078 | Acetylcholine nicotinic antagonist | |||
| 0.023 | 0.003 | 0.023 | Thyroid hormone beta agonist | |||
| 0.026 | 0.006 | 0.026 | Alpha 2a adrenoreceptor agonist | |||
| 0.069 | 0.05 | 0.069 | Amidase inhibitor | |||
| 0.03 | 0.011 | 0.03 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.056 | 0.038 | 0.056 | 5 Hydroxytryptamine 7 agonist | |||
| 0.038 | 0.02 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 CID_154700010 | ||
| 0.085 | 0.066 | 0.085 | Bromodomain-containing protein 2 inhibitor | |||
| 0.052 | 0.034 | 0.052 | Thromboxane A2 antagonist | |||
| 0.045 | 0.027 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.08 | 0.062 | 0.08 | Caspase 7 inhibitor | |||
| 0.04 | 0.022 | 0.04 | Delayed rectifier potassium channel blocker | |||
| 0.042 | 0.024 | 0.042 | Membrane dipeptidase inhibitor | |||
| 0.028 | 0.01 | 0.034 | Dopamine D1 agonist | 0.034 0.007 CID_154700010 | CID_154700010 | |
| 0.032 | 0.014 | 0.032 | Purinergic P2Y15 antagonist | |||
| 0.055 | 0.037 | 0.055 | Thromboxane antagonist | |||
| 0.06 | 0.042 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.029 | 0.011 | 0.029 | Prostaglandin E2 agonist | |||
| 0.029 | 0.012 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.022 | 0.005 | 0.022 | Thyroid hormone alpha agonist | |||
| 0.035 | 0.018 | 0.035 | HCV NS5B polymerase inhibitor | |||
| 0.113 | 0.096 | 0.113 | Toll-Like receptor antagonist | |||
| 0.074 | 0.058 | 0.18 | Topoisomerase II alpha inhibitor | 0.18 0.018 CID_154700010 | CID_154700010 | |
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | |||
| 0.114 | 0.098 | 0.114 | Histone deacetylase SIRT1 inhibitor | |||
| 0.04 | 0.024 | 0.04 | Farnesoid X receptor agonist | |||
| 0.023 | 0.007 | 0.023 | G-protein-coupled receptor 120 agonist | |||
| 0.035 | 0.019 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.027 | 0.011 | 0.027 | Glutamate (mGluR1a) agonist | |||
| 0.045 | 0.029 | 0.045 | Dopamine D5 antagonist | |||
| 0.052 | 0.036 | 0.052 | 5 Hydroxytryptamine 2 agonist | |||
| 0.065 | 0.05 | 0.065 | Cyclin B3 inhibitor | |||
| 0.038 | 0.023 | 0.038 | Progesterone antagonist | |||
| 0.042 | 0.027 | 0.042 | Kainate receptor antagonist | |||
| 0.065 | 0.05 | 0.065 | Acetylcholine M5 receptor agonist | |||
| 0.023 | 0.008 | 0.023 | Prostaglandin EP4 agonist | |||
| 0.021 | 0.006 | 0.03 | Telomerase stimulant | 0.03 0.003 CID_154700010 | CID_154700010 | |
| 0.05 | 0.036 | 0.05 | Prolyl endopeptidase inhibitor | |||
| 0.033 | 0.019 | 0.033 | Liver X receptor antagonist | |||
| 0.038 | 0.024 | 0.038 | Kainate receptor 2 antagonist | |||
| 0.032 | 0.018 | 0.032 | Complement C5a chemotactic receptor antagonist | |||
| 0.028 | 0.014 | 0.028 | NMDA receptor glycine site antagonist | |||
| 0.038 | 0.024 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.062 | 0.049 | 0.126 | Neuraminidase (influenza) inhibitor | 0.126 0.011 CID_154700010 | CID_154700010 | |
| 0.024 | 0.012 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 CID_154700010 | ||
| 0.032 | 0.02 | 0.032 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.025 | 0.012 | 0.025 | ICAM 1 antagonist | |||
| 0.017 | 0.004 | 0.017 | DNA polymerase III polC-type inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.067 | 0.056 | 0.067 | Calcium channel L-type blocker | |||
| 0.063 | 0.052 | 0.063 | Neuronal nicotinic receptor antagonist | |||
| 0.025 | 0.014 | 0.025 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.016 | 0.005 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.042 | 0.032 | 0.042 | Glutamate (mGluR4) antagonist | |||
| 0.034 | 0.024 | 0.034 | Calcitonin receptor agonist | |||
| 0.03 | 0.02 | 0.03 | Thiazolidinedione | |||
| 0.026 | 0.016 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.034 | 0.024 | 0.034 | RNA-directed RNA polymerase inhibitor | |||
| 0.043 | 0.034 | 0.043 | Oleamide hydrolase inhibitor | |||
| 0.042 | 0.032 | 0.042 | Opioid kappa receptor agonist | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha antagonist | |||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | |||
| 0.076 | 0.067 | 0.076 | Calcium antagonist | |||
| 0.069 | 0.059 | 0.069 | CDC25A inhibitor | |||
| 0.084 | 0.074 | 0.084 | Polo-like kinase-1 inhibitor | |||
| 0.036 | 0.027 | 0.036 | Kinesin-like protein 1 inhibitor | |||
| 0.036 | 0.027 | 0.036 | Kinesin antagonist | |||
| 0.052 | 0.043 | 0.052 | DNA helicase inhibitor | |||
| 0.018 | 0.009 | 0.018 | Calcium-sensing receptor antagonist | |||
| 0.03 | 0.021 | 0.03 | Glucagon receptor antagonist | |||
| 0.161 | 0.153 | 0.161 | ErbB-1 antagonist | |||
| 0.032 | 0.024 | 0.032 | Melatonin 2 agonist | |||
| 0.027 | 0.019 | 0.027 | Lysine carboxypeptidase inhibitor | |||
| 0.033 | 0.026 | 0.033 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.095 | 0.088 | 0.125 | Multidrug resistance-associated protein 1 inhibitor | 0.125 0.043 CID_154700010 | CID_154700010 | |
| 0.029 | 0.021 | 0.029 | AMPA 3 receptor antagonist | |||
| 0.051 | 0.044 | 0.051 | GABA receptor antagonist | |||
| 0.063 | 0.056 | 0.063 | Elastase 1 inhibitor | |||
| 0.042 | 0.035 | 0.042 | Histamine H1 receptor agonist | |||
| 0.025 | 0.019 | 0.025 | Complement factor 1s inhibitor | |||
| 0.047 | 0.041 | 0.091 | Aldose reductase inhibitor | 0.091 0.02 CID_154700010 | CID_154700010 | |
| 0.046 | 0.04 | 0.046 | Potassium channel (Inward rectifier) blocker | |||
| 0.026 | 0.021 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.101 | 0.096 | 0.101 | Nav1.3 sodium channel blocker | |||
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.03 | 0.025 | 0.03 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.11 | 0.105 | 0.11 | Interleukin 1 antagonist | |||
| 0.138 | 0.133 | 0.138 | I kappa B kinase epsilon inhibitor | |||
| 0.012 | 0.007 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.058 | 0.054 | 0.058 | Dopamine agonist | |||
| 0.059 | 0.055 | 0.059 | Matrix metalloproteinase inhibitor | |||
| 0.03 | 0.026 | 0.03 | Sirtuin 2 inhibitor | |||
| 0.026 | 0.022 | 0.026 | AMPA 1 receptor antagonist | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.034 | 0.03 | 0.034 | G protein-coupled receptor agonist | |||
| 0.018 | 0.015 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.022 | 0.018 | 0.022 | Dopamine autoreceptor agonist | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.018 | 0.015 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.038 | 0.035 | 0.038 | Carbonic anhydrase IV inhibitor | |||
| 0.035 | 0.032 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.021 | 0.018 | 0.021 | CYP24 inhibitor | |||
| 0.014 | 0.011 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.119 | 0.116 | 0.119 | MAP3K9 inhibitor | |||
| 0.057 | 0.054 | 0.057 | 5 Hydroxytryptamine 3 agonist | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.047 | 0.045 | 0.047 | GABA A receptor antagonist | |||
| 0.054 | 0.052 | 0.074 | Lipocortins synthesis agonist | 0.074 0.018 CID_154700010 | CID_154700010 | |
| 0.076 | 0.074 | 0.076 | Thioredoxin reductase inhibitor | |||
| 0.015 | 0.013 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.143 | 0.141 | 0.143 | Aryl hydrocarbon receptor agonist | |||
| 0.011 | 0.009 | 0.011 | Egl nine homolog 3 inhibitor | |||
| 0.017 | 0.015 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.056 | 0.054 | 0.056 | Prostaglandin F2 alpha antagonist | |||
| 0.026 | 0.024 | 0.026 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.02 | 0.018 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | |||
| 0.044 | 0.042 | 0.044 | Matrix metalloproteinase 1 inhibitor | |||
| 0.013 | 0.012 | 0.013 | Egl nine homolog 1 inhibitor | |||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.071 | 0.07 | 0.071 | Chymotrypsin inhibitor | |||
| 0.039 | 0.038 | 0.039 | DNA gyrase subunit A inhibitor | |||
| 0.01 | 0.009 | 0.01 | Beta 3 adrenoreceptor agonist | |||
| 0.045 | 0.047 | 0.145 | Protein 50S ribosomal subunit inhibitor | 0.145 0.007 CID_154700010 | CID_154700010 | |
| 0.066 | 0.068 | 0.252 | Antineoplastic antibiotic | 0.252 0.014 CID_154700010 | CID_154700010 | |
| 0.026 | 0.029 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_154700010 | CID_154700010 | |
| 0.078 | 0.084 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.134 0.012 CID_154700010 | CID_154700010 | |
| 0.008 | 0.014 | 0.012 | Purinergic P2Y2 agonist | 0.012 0.005 CID_154700010 | CID_154700010 | |
| 0.051 | 0.058 | 0.437 | Selectin antagonist | 0.437 0.003 CID_154700010 | CID_154700010 | |
| 0.05 | 0.058 | 0.106 | Neuraminidase inhibitor | 0.106 0.013 CID_154700010 | CID_154700010 | |
| 0.093 | 0.105 | 0.397 | Cell adhesion inhibitor | 0.397 0.005 CID_154700010 | CID_154700010 | |
| 0.083 | 0.097 | 0.172 | DNA intercalator | 0.172 0.035 CID_154700010 | CID_154700010 | |
| 0.109 | 0.124 | 0.37 | Thrombolytic | 0.37 0.014 CID_154700010 | CID_154700010 | |
| 0.02 | 0.036 | 0.063 | Squalene synthetase inhibitor | 0.063 0.011 CID_154700010 | CID_154700010 | |
| 0.032 | 0.048 | 0.124 | Phosphorylase inhibitor | 0.124 0.01 CID_154700010 | CID_154700010 | |
| 0.041 | 0.057 | 0.12 | Factor IXa inhibitor | 0.12 0.006 CID_154700010 | CID_154700010 | |
| 0.14 | 0.156 | 0.393 | Platelet antagonist | 0.393 0.028 CID_154700010 | CID_154700010 | |
| 0.035 | 0.056 | 0.065 | Neuraminidase (Influenza A) inhibitor | 0.065 0.009 CID_154700010 | CID_154700010 | |
| 0.032 | 0.054 | 0.072 | Carbonic anhydrase XII inhibitor | 0.072 0.028 CID_154700010 | CID_154700010 | |
| 0.003 | 0.038 | 0.018 | Antibiotic Macrolide-like | 0.018 0.008 CID_154700010 | CID_154700010 | |
| 0.072 | 0.108 | 0.108 | T cell inhibitor | 0.108 0.019 CID_154700010 | CID_154700010 | |
| 0.011 | 0.05 | 0.021 | Corticosteroid-like | 0.021 0.015 CID_154700010 | CID_154700010 | |
| 0.014 | 0.056 | 0.069 | Protein 30S ribosomal subunit inhibitor | 0.069 0.005 CID_154700010 | CID_154700010 | |
| 0.067 | 0.11 | 0.172 | Transcription factor NF kappa B stimulant | 0.172 0.012 CID_154700010 | CID_154700010 | |
| 0.049 | 0.094 | 0.107 | Histone deacetylase SIRT1 stimulant | 0.107 0.024 CID_154700010 | CID_154700010 | |
| 0.049 | 0.094 | 0.107 | Histone deacetylase stimulant | 0.107 0.024 CID_154700010 | CID_154700010 | |
| 0.06 | 0.117 | 0.122 | Falcipain inhibitor | 0.122 0.043 CID_154700010 | CID_154700010 | |
| 0.058 | 0.117 | 0.119 | Falcipain 2 inhibitor | 0.119 0.042 CID_154700010 | CID_154700010 | |
| 0.04 | 0.105 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.045 CID_154700010 | CID_154700010 | |
| 0.023 | 0.088 | 0.088 | Antibiotic Aminoglycoside-like | 0.088 0.004 CID_154700010 | CID_154700010 | |
| 0.027 | 0.102 | 0.053 | Microtubule stabilization | 0.053 0.024 CID_154700010 | CID_154700010 | |
| 0.011 | 0.093 | 0.034 | Motilin receptor agonist | 0.034 0.008 CID_154700010 | CID_154700010 | |
| 0.017 | 0.105 | 0.038 | Toll-Like receptor 4 agonist | 0.038 0.005 CID_154700010 | CID_154700010 | |
| 0.052 | 0.141 | 0.22 | Cell adhesion molecule inhibitor | 0.22 0.008 CID_154700010 | CID_154700010 | |
| 0.147 | 0.279 | 0.316 | Antiobesity | 0.316 0.106 CID_154700010 | CID_154700010 | |
| 0.022 | 0.2 | 0.075 | Nitric oxide donor | 0.075 0.027 CID_154700010 | CID_154700010 | |
| 0.106 | 0.341 | 0.516 | Immunomodulator | 0.516 0.021 CID_154700010 | CID_154700010 | |
| 0.005 | 0.284 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.013 CID_154700010 | CID_154700010 | |
| 0.012 | 0.388 | 0.057 | DNA gyrase inhibitor | 0.057 0.052 CID_154700010 | CID_154700010 | |
| 0.031 | 0.421 | 0.27 | Anticoagulant | 0.27 0.034 CID_154700010 | CID_154700010 | |
| 0.048 | 0.498 | 0.245 | Angiogenesis inhibitor | 0.245 0.127 CID_154700010 | CID_154700010 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |